Menopausal Status Should Be Taken Into Consideration for Patients With Luminal A Breast Cancer in Terms of the Effect of Differential Biology on Prognosis-Reference-Cited by-同舟云学术

Menopausal Status Should Be Taken Into Consideration for Patients With Luminal A Breast Cancer in Terms of the Effect of Differential Biology on Prognosis

Published:2013-07-01 Issue:19 Volume:31 Page:2516-2516
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Yamamoto Yutaka¹,Yamamoto-Ibusuki Mutsuko¹,Iwase Hirotaka¹

Affiliation:

1. Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.49.4062

Reference5 articles.

1. Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

2. Adrenal Suppression with Aminoglutethimide. II. Differential Effects of Aminoglutethimide on Plasma Androstenedione and Estrogen Levels12

3. Tumor Variants by Hormone Receptor Expression in White Patients With Node-Negative Breast Cancer From the Surveillance, Epidemiology, and End Results Database

4. Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis

5. Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Menopausal Status, Expression of Progesterone Receptor and Ki67 to the Clinical Response to Neoadjuvant Chemotherapy in Luminal Breast Cancer;Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics;2019-12

2. Clinicopathological characteristics of patients of certain molecular subtypes and elevated postoperative cancer antigen 15.3 levels and its correlation with menopausal status;Indian Journal of Pathology and Microbiology;2016

3. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer;Breast Cancer;2015-10-14

4. Tumor biology in estrogen receptor-positive, human epidermal growth factor receptor type 2-negative breast cancer: Mind the menopausal status;World Journal of Clinical Oncology;2015

5. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer;Breast Cancer Research and Treatment;2014-02-19